by adminmps | Sep 9, 2022 | News
CTV Kitchener. has featured a story on one of our children, Joseph Saliba, who lives with Sanfilippo Syndrome to raise awareness of MPS. There is no cure for this type of MPS but there is a trial underway for gene therapy, that could help prolong life. The trial,...
by adminmps | Sep 6, 2022 | News, Resources
Listen to a talk about the sibling perspective and the support available with Emily Holl, the Director of the Sibling Support Project. Emily is a social worker, writer, trainer, and sibling. Over the past 16 years, she has provided workshops, training, and groups for...
by adminmps | Sep 6, 2022 | News
On June 30, 2022, The Patented Medicine Prices Review Board (PMPRB) issued a Notice and Comment on its proposed approach for reviewing the prices of patented medicines during the period between the coming into force of the recently amended...
by adminmps | Sep 6, 2022 | News, Resources
Want to find out more about anaesthesia and how it relates to rare diseases? OrphanAnesthesia publishes anaesthesia recommendations for rare diseases in order to facilitate the work of anaesthesiologists and to improve patients’ safety. This a project of the...
by adminmps | Sep 6, 2022 | News
The Department of Health and Human Services (DHHS) in the United States has approved adding MPS II as a condition to the recommended uniform screening panel (RUSP) for newborns. This enables several states to begin testing newborns immediately. Early diagnosis...
by adminmps | Sep 6, 2022 | Clinical Trials, News, Research
In our March edition we reported that Abeona Therapeutics had decided to end enrollment for their clinical trial for MPS IIIA children. We are now happy to share that Ultragenyx will be taking over the clinical trials for AAV gene therapy ABO-102 (now UX111). “Based...
